Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ,2 ]
Mendes, Diogo [2 ]
Penedones, Ana [1 ,2 ]
Marques, Francisco Batel [1 ,2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4457
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [1] Comparative Efficacy and Safety of JAK Inhibitors in the Management of Rheumatoid Arthritis: A Network Meta-Analysis
    Almoallim, Hani M.
    Omair, Mohammed A.
    Ahmed, Sameh A.
    Vidyasagar, Kota
    Sawaf, Bisher
    Yassin, Mohamed A.
    PHARMACEUTICALS, 2025, 18 (02)
  • [2] Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials
    Alves, Carlos
    Mendes, Diogo
    Penedones, Ana
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 130 - 130
  • [3] RISK OF INFECTIONS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Batel-Marques, Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 25 - 25
  • [4] Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis
    Wang, Faping
    Tang, Xiaoju
    Zhu, Min
    Mao, Hui
    Wan, Huajing
    Luo, Fengming
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [5] JAK inhibitors and the risk of cardiovascular and venous thromboembolism events among patients with rheumatoid arthritis: A network meta-analysis of clinical trials
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 86 - 86
  • [6] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Janet Pope
    Ruta Sawant
    Namita Tundia
    Ella X. Du
    Cynthia Z. Qi
    Yan Song
    Patrick Tang
    Keith A. Betts
    Advances in Therapy, 2020, 37 : 2356 - 2372
  • [7] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Du, Ella X.
    Qi, Cynthia Z.
    Song, Yan
    Tang, Patrick
    Betts, Keith A.
    ADVANCES IN THERAPY, 2020, 37 (05) : 2356 - 2372
  • [8] Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials
    Pugliesi, Alisson
    Chicre Oliveira, Daniela Gomes
    de Souza Filho, Vani Abreu
    Machado, Julia de Oliveira
    Pereira, Aline Gonsalves
    Silveira Bichuette, Julia de Castro
    Sachetto, Zoraida
    de Carvalho, Luiz Sergio F.
    Bertolo, Manoel Barros
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [9] Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis
    Zhang, Xiaogang
    Zhang, Mingming
    Wang, Zhiqiang
    Liu, Yanqing
    Feng, Xing
    Yang, Liu
    Wang, Yajing
    Liu, Juan
    Zhao, Dongbao
    MEDICINE, 2022, 101 (49) : E32154
  • [10] RISK OF CARDIOVASCULAR AND VENOUS THROMBOEMBOLISM EVENTS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Batel-Marques, Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 25 - 25
12345